ArticleEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin2020
Article in Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 37 citations in OpenAlex.
- Impact of COVID-19 pandemic on Legionella testing and infection rates in Ontario.BMC public health · 2025Article
- The Global Burden and Trends of Legionella spp. Infection-Associated Diseases from 1990 to 2021: An Observational Study.Journal of epidemiology and global health · 2025Observational
- Article
- Editorial: Special Issue: "Microorganisms · 2023Article
- Legionnaires' Disease in Occupational Settings: A Cross-Sectional Study from Northeastern Italy (2019).Tropical medicine and infectious disease · 2023Article
- Increased Incidence of Legionellosis after Improved Diagnostic Methods, New Zealand, 2000-2020.Emerging infectious diseases · 2023Article
- Environmental Monitoring ofInternational journal of environmental research and public health · 2023Article
- Evaluation of Biopolymer Materials and Synthesis Techniques to Develop a Rod-Shaped Biopolymer Surrogate forPolymers · 2022Article
- Potential environmental and health risk when returning to normal amidst COVID-19 vaccination.Current opinion in environmental science & health · 2022Review
- Impact of lockdown and non-pharmaceutical interventions on the epidemiology of Legionnaires' disease.Acta bio-medica : Atenei Parmensis · 2022Article
- Overview of the Clinical and Molecular Features of Legionella Pneumophila: Focus on Novel Surveillance and Diagnostic Strategies.Antibiotics (Basel, Switzerland) · 2022Review
- Changing Epidemiology of Respiratory Tract Infection during COVID-19 Pandemic.Antibiotics (Basel, Switzerland) · 2022Review
- SARS-CoV-2-Legionella Co-Infections: A Systematic Review and Meta-Analysis (2020-2021).Microorganisms · 2022Review
- Consequences of the COVID-19 Outbreak Lockdown on Non-Viral Infectious Agents as Reported by a Laboratory-Based Surveillance System at the IHU Méditerranée Infection, Marseille, France.Journal of clinical medicine · 2021Article
- The Role of Lipids inInternational journal of molecular sciences · 2021Review
- Legionella and SARS-CoV-2 Coinfection in a Patient With Pneumonia - An Outbreak in Northern Portugal.Cureus · 2021Article
- Letter to the editor: importance of a careful investigation to avoid attributing Legionnaires' disease cases to an incorrect source of infection.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2020Article
- Severe ARDS Secondary toJournal of investigative medicine high impact case reportsArticle
Corrections and comments
- Commented on by
- Commented on by
Authors and funding
11 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We report a case of
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.